Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/13/2009
 
First Published:
8/18/2006
1.
Phase III Randomized Study of Donepezil Hydrochloride in Patients Who Have Undergone Partial- or Whole-Brain Irradiation for Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
NCI
CCCWFU-91105
WFU 91105, NCT00369785
2.
Efficacy and Safety Study of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
6 to 17
Pharmaceutical / Industry
E2020-G000-334
NCT00687635
3.
Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
6 to 17
Pharmaceutical / Industry
E2020-G000-333
NCT00688376
Last Modified:
12/13/2007
 
First Published:
3/22/2007
4.
Pilot Study of Donepezil Hydrochloride in Pediatric Patients With Primary Brain Tumors Previously Treated With Cranial Radiotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
8 to 17
NCI
CCCWFU-91305
CCCWFU-IRB-00000258, CCCWFU 91305, NCT00452868
5.
Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
18 and over
Other
04-122
NCT00594633
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute